A Real-World Analysis of Relapse Rate and Efficacy of a Restricted Monthly Dose of Omalizumab in Recalcitrant Chronic Spontaneous Urticaria in India
Indian Dermatol Online J
.
2020 Sep 19;11(5):835-837.
doi: 10.4103/idoj.IDOJ_499_19.
eCollection 2020 Sep-Oct.
Authors
Kabir Sardana
1
,
Niharika Dixit
1
,
Pooja Arora
1
Affiliation
1
Department of Dermatology, Venereology and Leprosy, Dr. Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research, Baba Kharak Singh Marg, New Delhi, India.
PMID:
33235861
PMCID:
PMC7678515
DOI:
10.4103/idoj.IDOJ_499_19
No abstract available